In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019
Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine
Published ·

Keep reading
Related stories



Published ·

In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019
Keep reading


